Men with sneaky testosterone physiology have worse prostate cancer outcomes, study finds

First-of-its-kind study on 266 men found 20% have higher levels of the hormone in the vessels surrounding the prostate.

IDE-161 by Ideaya Biosciences for Metastatic Ovarian Cancer: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 22, 2023

Approval by the Extraordinary General Meeting of the acquisition of almost all assets and corresponding change of the statutory purpose of the Company – Biotech Investments

Epigenomics AG / Key word(s): AGM/EGM Epigenomics AG: Approval by the Extraordinary General Meeting of the acquisition of almost all assets and corresponding change of

September 12, 2023

Mydecine Receives Management Cease Trade Order | Psychedelic Invest

VANCOUVER, British Columbia, May 2, 2024 (TheNewswire) — Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) (AQSE: MYIG) announces that it has received a temporary

May 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.